Li et al. screened 4536 women who had previously had a negative result from BRCA1 and BRCA2 mutation testing, had a family history of breast cancer and a personal history of breast cancer (> 95%) or ovarian cancer. This evidence concerns the gene BRCA2 and breast cancer.